Havens Advisors’s Immunomedics Inc IMMU Stock Holding History

Havens Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-96,000	Closed	-$8.16M	–	48
2020 Q3	$8.16M	Buy	+96,000	New	+$4.85M	7.56%	3

Havens Advisors's IMMU Position: Q4 2020 in Review

Havens Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 96,000 shares — an estimated $8.16M sold.

Havens Advisors first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $8.16M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Havens Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Havens Advisors sold 96,000 Immunomedics Inc shares in Q4 2020, an estimated $8.16M.
Havens Advisors first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Havens Advisors's Immunomedics Inc position peaked at $8.16M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Havens Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.